Linking a policy on nonformulary drugs to the FDA's therapeutic-potential classification system.
Explore the source record for details and available documents.
Drug Approval↗
Biomedical subjects
Publications and source records attributed to M Vorbach.
Explore the source record for details and available documents.
Congenital lobar emphysema is mainly seen in new-born and young babies. In the first hours or days, symptoms appear such as dyspnea, cyanosis, tachypnea, wheezing, thoracic and epigastric retractions. Later symptoms are faintness, psychomotoric retardation and malformation of the thorax. Etiology and pathogenesis of this emphysema of individual parts of the lung are unclear. The course is paroxysmatic, persistent or chronic. Preferred therapy of choice is the resection of the parts concerned. After operation the prognosis is good.